CCLD

CareCloud Inc. (CCLD) | Rumor.io

CareCloud

CCLD

Attention (50-day avg)0%

Attention rank (50-day avg)#2,736

Bullish sentiment (50-day avg)90%

Price to earnings ratio29.3

Market capitalization87.1M

Earnings per share0.07

Dividend yield (TTM)—

Revenue (annual)120.5M

Net income (annual)10.8M

Social

What share of all stock conversation is about CCLD?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% 0	0% 0	0% 0

Aug 6

CareCloud's Q2 results were in line with the street and modestly ahead of Zacks on both top and bottom lines, with softer professional services revenue.
The company's cash flow is healthy, with no ATM equity issuance, and management is guiding conservatively with the potential for revenue to start growing faster.
CareCloud's Q2 results showed a 16.45% YoY revenue increase, with a reported revenue of $31.88M, and the company reaffirmed its full-year 2026 guidance.

Generated by AI

Sentiment

Of the messages about CCLD that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	100% +12.4	85.57% -3.58
Bearish	—	—	0% -12.4	14.43% +3.58

Bullish· May 7

CareCloud's 600% earnings beat has been largely overlooked by the market, presenting a potential buying opportunity.
The company's AI strategy has transitioned from promises to performance, with the recent earnings report demonstrating its capabilities.
Despite the impressive earnings report, the stock has not yet experienced a significant price increase, suggesting that it may be due for a substantial move upwards.

Bearish· Mar 13

CareCloud, Inc. ($CCLD) has executed a stock conversion that has raised questions about its value, leading to a significant drop.
The company's fundamentals are good, but its stock price is disconnected from reality, suggesting a potential for a price correction.
The stock has broken its earnings per share (EPS) and has dropped by over 50% despite exceptional news, indicating a possible overvaluation.

Generated by AI

Topics

Of the messages about CCLD that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	100%	100%	75%	44.3%
Technical Analysis	0%	0%	25%	26.11%
Earnings	0%	0%	0%	27.3%
Analysts	0%	0%	0%	0.94%
Macro	0%	0%	0%	1.36%
Controversies	0%	0%	0%	0%

Announcements· Aug 25

CareCloud, Inc. ($CCLD) acquired Medsphere Systems, a provider of healthcare IT software and services, for $16.5 million, expanding its presence in the hospital IT market.
The acquisition adds approximately 600 small and mid-sized hospital clients and a full suite of inpatient IT solutions to CareCloud's offerings, including EHR, RCM, emergency care, and supply chain tools.
The deal is expected to bring in $50M-$100M in revenue, and integrate Medsphere's proven systems with CareCloud's AI infrastructure to empower affordable, scalable digital health tools across the care continuum.

Technical Analysis· May 13

$CCLD is in a downtrend, but may break out above $2.60.
A bullish pennant and a falling wedge breakout on 1D demand are potential patterns for $CCLD.
$CCLD needs to break $2.20 to continue its upward movement, with potential targets at $2.85.

Generated by AI

Community

Of the messages about CCLD, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	50%	50%	46.67%	46.23%
Newcomers	50%	50%	53.33%	53.77%

Regulars· Aug 6

Results for Q2 came in roughly in line with the Street and modestly ahead of Zacks on both the top and bottom line, with softer professional services (PS) revenue contributing to the shortfall.
The company's recurring revenue growth accelerated to $25 million, up from $19 million year-over-year, and adjusted EBITDA came in at $5.9 million, with management reaffirming FY2026 guidance.
Management seems upbeat, guiding conservatively, and there is potential for revenue to start growing much faster, with a couple of good PRs in the coming months, and the company continues to make profit with solid earnings.

Newcomers· May 7

Newcomers to the stock are excited about the 600% earnings beat and the company's AI strategy, with some expecting a significant price increase in the coming days.
The stock's low valuation, trading at less than 6x FCF, is seen as a reason to hold the stock long-term, with some expecting it to reach $10-$20 in the long run.
Despite the significant earnings beat, the stock is still under the radar, with some users expecting a stair-step price increase over the coming days, and others treating dips as "gifts" until proven otherwise.

Generated by AI

Bilbel Capital, an investment management company, released its second-quarter 2026 investment letter. The letter can be downloaded here. The strategy returned -15.7%, gross and -16.1%, net, in the first half of 2026, compared to a 10.2% return for the S&P 500 Index. The letter outlines top positions, all acquired under 3.5 times a normal year’s […]

1mo agoYahoo Finance

CareCloud confirms 3.7M patients had their medical records stolen in data breach | TechCrunch

The cyberattack at CareCloud resulted in one of the largest reported data breaches in the U.S. healthcare industry this year.

1mo agoTechCrunch

KabaFusion Selects CareCloud to Build First-of-Its-Kind Platform for Home Infusion and Specialty Pharmacy

KabaFusion partners with CareCloud to develop a fully integrated application, powered by artificial intelligence, designed for the home infusion workflow Somerset, NJ and Lexington, MA, Aug. 18, 2026 (GLOBE NEWSWIRE) -- KabaFusion, one of the nation's largest providers of home infusion therapy, and CareCloud, Inc. (Nasdaq: CCLD) (“CareCloud” or the “Company”), a leader in healthcare technology, today announced a partnership to build LailaCare, a platform powered by artificial intelligence and de

1mo agoYahoo Finance

CareCloud (CCLD) Q2 2026 Earnings Call Transcript

Detailed price information for Citizens Financial Group (CFG-N) from The Globe and Mail including charting and trades.

1mo agoThe Globe and Mail

CCLD: With its Series B Preferred Redeemed and Merger Integration Costs Mostly Over, CareCloud Looks to EPS Growth Going Forward

By Lisa Thompson NASDAQ: CCLD READ THE FULL CCLD RESEARCH REPORT CareCloud (NASDAQ: CCLD) had a productive quarter with the elimination of the Series B Preferred and replacing it with tax-deductible and lower-cost debt. This should be a big benefit to common shareholders in both cost and a simplified, understandable balance sheet. During the quarter, the company acquired Empower Healthcare and

1mo agoYahoo Finance

Also Discussed

Investors talking about CCLD also mention

#	Name	Attention
1	CCLDO - CareCloud, Inc.	——
2	Myomo Inc.MYO	0%0
3	Armata Pharmaceuticals, Inc.ARMP	0%0
4	Anixa Biosciences, Inc.ANIX	0%new
5	Peraso Inc.PRSO	0%0
6	Delcath Systems, Inc.DCTH	0%new
7	The Bancorp, Inc.TBBK	0%new
8	Statera Biopharma Inc.STAB	0%0
9	China Auto Logistics Inc.CALI	0.06%-0.49
10	GLG - TD Holdings, Inc.	——

CareCloud Inc.

Healthcare
Health Information Services

CareCloud Inc. is a healthcare information technology company that provides cloud-based software and related services for medical practices, health systems, and hospitals. Its core offerings center on revenue cycle management, practice management, electronic health records, telehealth, patient experience management, and business intelligence, helping healthcare organizations coordinate clinical, financial, and administrative workflows. The company also offers complementary professional services, including implementation support, consulting, and staffing solutions, with products designed to improve operational efficiency and simplify day-to-day practice operations. CareCloud serves providers across the United States through a SaaS-based platform built for a range of specialties and care settings. Headquartered in Somerset, New Jersey, CareCloud focuses on technology-enabled tools that support modern healthcare delivery and back-office management.

Website

Location

7 Clyde Road

Somerset, NJ, 08873

United States

Social

What share of all stock conversation is about CCLD?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% 0	0% 0	0% 0

Aug 6

CareCloud's Q2 results were in line with the street and modestly ahead of Zacks on both top and bottom lines, with softer professional services revenue.
The company's cash flow is healthy, with no ATM equity issuance, and management is guiding conservatively with the potential for revenue to start growing faster.
CareCloud's Q2 results showed a 16.45% YoY revenue increase, with a reported revenue of $31.88M, and the company reaffirmed its full-year 2026 guidance.

Generated by AI

Sentiment

Of the messages about CCLD that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	100% +12.4	85.57% -3.58
Bearish	—	—	0% -12.4	14.43% +3.58

Bullish· May 7

CareCloud's 600% earnings beat has been largely overlooked by the market, presenting a potential buying opportunity.
The company's AI strategy has transitioned from promises to performance, with the recent earnings report demonstrating its capabilities.
Despite the impressive earnings report, the stock has not yet experienced a significant price increase, suggesting that it may be due for a substantial move upwards.

Bearish· Mar 13

CareCloud, Inc. ($CCLD) has executed a stock conversion that has raised questions about its value, leading to a significant drop.
The company's fundamentals are good, but its stock price is disconnected from reality, suggesting a potential for a price correction.
The stock has broken its earnings per share (EPS) and has dropped by over 50% despite exceptional news, indicating a possible overvaluation.

Generated by AI

Topics

Of the messages about CCLD that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	100%	100%	75%	44.3%
Technical Analysis	0%	0%	25%	26.11%
Earnings	0%	0%	0%	27.3%
Analysts	0%	0%	0%	0.94%
Macro	0%	0%	0%	1.36%
Controversies	0%	0%	0%	0%

Announcements· Aug 25

CareCloud, Inc. ($CCLD) acquired Medsphere Systems, a provider of healthcare IT software and services, for $16.5 million, expanding its presence in the hospital IT market.
The acquisition adds approximately 600 small and mid-sized hospital clients and a full suite of inpatient IT solutions to CareCloud's offerings, including EHR, RCM, emergency care, and supply chain tools.
The deal is expected to bring in $50M-$100M in revenue, and integrate Medsphere's proven systems with CareCloud's AI infrastructure to empower affordable, scalable digital health tools across the care continuum.

Technical Analysis· May 13

$CCLD is in a downtrend, but may break out above $2.60.
A bullish pennant and a falling wedge breakout on 1D demand are potential patterns for $CCLD.
$CCLD needs to break $2.20 to continue its upward movement, with potential targets at $2.85.

Generated by AI

Community

Of the messages about CCLD, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	50%	50%	46.67%	46.23%
Newcomers	50%	50%	53.33%	53.77%

Regulars· Aug 6

Results for Q2 came in roughly in line with the Street and modestly ahead of Zacks on both the top and bottom line, with softer professional services (PS) revenue contributing to the shortfall.
The company's recurring revenue growth accelerated to $25 million, up from $19 million year-over-year, and adjusted EBITDA came in at $5.9 million, with management reaffirming FY2026 guidance.
Management seems upbeat, guiding conservatively, and there is potential for revenue to start growing much faster, with a couple of good PRs in the coming months, and the company continues to make profit with solid earnings.

Newcomers· May 7

Newcomers to the stock are excited about the 600% earnings beat and the company's AI strategy, with some expecting a significant price increase in the coming days.
The stock's low valuation, trading at less than 6x FCF, is seen as a reason to hold the stock long-term, with some expecting it to reach $10-$20 in the long run.
Despite the significant earnings beat, the stock is still under the radar, with some users expecting a stair-step price increase over the coming days, and others treating dips as "gifts" until proven otherwise.

Generated by AI

CareCloud

Social

Aug 6

Bullish· May 7

Bearish· Mar 13

Announcements· Aug 25

Technical Analysis· May 13

Regulars· Aug 6

Newcomers· May 7

CareCloud promotes Bonnie Boyer to chief financial officer

Bilbel Capital Sold CareCloud (CCLD) for More Attractive Opportunities

CareCloud confirms 3.7M patients had their medical records stolen in data breach | TechCrunch

KabaFusion Selects CareCloud to Build First-of-Its-Kind Platform for Home Infusion and Specialty Pharmacy

CareCloud (CCLD) Q2 2026 Earnings Call Transcript

CCLD: With its Series B Preferred Redeemed and Merger Integration Costs Mostly Over, CareCloud Looks to EPS Growth Going Forward

Also Discussed

CareCloud Inc.

Company Information

Location

CareCloud promotes Bonnie Boyer to chief financial officer

Bilbel Capital Sold CareCloud (CCLD) for More Attractive Opportunities

CareCloud confirms 3.7M patients had their medical records stolen in data breach | TechCrunch

KabaFusion Selects CareCloud to Build First-of-Its-Kind Platform for Home Infusion and Specialty Pharmacy

CareCloud (CCLD) Q2 2026 Earnings Call Transcript

CCLD: With its Series B Preferred Redeemed and Merger Integration Costs Mostly Over, CareCloud Looks to EPS Growth Going Forward

Also Discussed

Social

Aug 6

Bullish· May 7

Bearish· Mar 13

Announcements· Aug 25

Technical Analysis· May 13

Regulars· Aug 6

Newcomers· May 7